MiR-27b-3p promotes migration and invasion in colorectal cancer cells by targeting HOXA10. 2019

Xiangling Yang, and Junxiong Chen, and Yao Liao, and Lanlan Huang, and Chuangyu Wen, and Mengmeng Lin, and Weiqian Li, and Yonglin Zhu, and Xiaojian Wu, and Aikichi Iwamoto, and Zhongyang Wang, and Huanliang Liu
Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Dysregulation of microRNAs (miRNAs) contributes to tumor progression via the regulation of the expression of specific oncogenes and tumor suppressor genes. One such example, miR-27b-3p, has reportedly been involved in tumor progression in many types of cancer. The aim of the present study was to delve into the role and the underlying mechanism of miR-27b-3p in colorectal cancer (CRC) cells. In the present study, we detected the expression level of miR-27b-3p by RT-PCR. The effect of miR-27b-3p overexpression on cell proliferation in CRC cells was evaluated by cell counting and Edu assays. Transwell migration and invasion assays were used to examine the effects of cell migration and invasion. Bioinformatics, luciferase reporter assay and western blot assay were performed to identify the target of miR-27b-3p. Here, we have demonstrated that although miR-27b-3p can affect cell morphology, it has no observable effect on the proliferation of CRC cells. However, it significantly promotes the migration and invasion of CRC cells. We discovered that HOXA10 was a newly identified target of miR-27b-3p in CRC cells, as confirmed by bioinformatics, western blots and dual luciferase reporter assay. Furthermore, the overexpression of miR-27b-3p or the suppression of HOXA10 can activate the integrin β1 signaling pathway. In conclusion, our results reveal a new function of miR-27b-3p that demonstrates its ability to promote CRC cell migration and invasion by targeting the HOXA10/integrin β1 cell signal axis. This may provide a mechanism to explain why miR-27b-3p promotes CRC cell migration and invasion.

UI MeSH Term Description Entries
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000080905 Homeobox A10 Proteins Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis of tissues. They bind to the DNA sequence 5'-AA[AT]TTTTATTAC-3'. HOXA 10 Proteins,HOXA10 Proteins,Homeo Box A10 Proteins,Homeobox A10,10 Proteins, HOXA,A10 Proteins, Homeobox,A10, Homeobox,Proteins, HOXA 10,Proteins, HOXA10
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Xiangling Yang, and Junxiong Chen, and Yao Liao, and Lanlan Huang, and Chuangyu Wen, and Mengmeng Lin, and Weiqian Li, and Yonglin Zhu, and Xiaojian Wu, and Aikichi Iwamoto, and Zhongyang Wang, and Huanliang Liu
January 2017, International journal of clinical and experimental pathology,
Xiangling Yang, and Junxiong Chen, and Yao Liao, and Lanlan Huang, and Chuangyu Wen, and Mengmeng Lin, and Weiqian Li, and Yonglin Zhu, and Xiaojian Wu, and Aikichi Iwamoto, and Zhongyang Wang, and Huanliang Liu
October 2019, European review for medical and pharmacological sciences,
Xiangling Yang, and Junxiong Chen, and Yao Liao, and Lanlan Huang, and Chuangyu Wen, and Mengmeng Lin, and Weiqian Li, and Yonglin Zhu, and Xiaojian Wu, and Aikichi Iwamoto, and Zhongyang Wang, and Huanliang Liu
January 2019, Biotechnology and applied biochemistry,
Xiangling Yang, and Junxiong Chen, and Yao Liao, and Lanlan Huang, and Chuangyu Wen, and Mengmeng Lin, and Weiqian Li, and Yonglin Zhu, and Xiaojian Wu, and Aikichi Iwamoto, and Zhongyang Wang, and Huanliang Liu
January 2018, American journal of cancer research,
Xiangling Yang, and Junxiong Chen, and Yao Liao, and Lanlan Huang, and Chuangyu Wen, and Mengmeng Lin, and Weiqian Li, and Yonglin Zhu, and Xiaojian Wu, and Aikichi Iwamoto, and Zhongyang Wang, and Huanliang Liu
January 2020, OncoTargets and therapy,
Xiangling Yang, and Junxiong Chen, and Yao Liao, and Lanlan Huang, and Chuangyu Wen, and Mengmeng Lin, and Weiqian Li, and Yonglin Zhu, and Xiaojian Wu, and Aikichi Iwamoto, and Zhongyang Wang, and Huanliang Liu
January 2019, OncoTargets and therapy,
Xiangling Yang, and Junxiong Chen, and Yao Liao, and Lanlan Huang, and Chuangyu Wen, and Mengmeng Lin, and Weiqian Li, and Yonglin Zhu, and Xiaojian Wu, and Aikichi Iwamoto, and Zhongyang Wang, and Huanliang Liu
March 2012, BMC cancer,
Xiangling Yang, and Junxiong Chen, and Yao Liao, and Lanlan Huang, and Chuangyu Wen, and Mengmeng Lin, and Weiqian Li, and Yonglin Zhu, and Xiaojian Wu, and Aikichi Iwamoto, and Zhongyang Wang, and Huanliang Liu
January 2017, American journal of cancer research,
Xiangling Yang, and Junxiong Chen, and Yao Liao, and Lanlan Huang, and Chuangyu Wen, and Mengmeng Lin, and Weiqian Li, and Yonglin Zhu, and Xiaojian Wu, and Aikichi Iwamoto, and Zhongyang Wang, and Huanliang Liu
January 2019, International journal of clinical and experimental pathology,
Xiangling Yang, and Junxiong Chen, and Yao Liao, and Lanlan Huang, and Chuangyu Wen, and Mengmeng Lin, and Weiqian Li, and Yonglin Zhu, and Xiaojian Wu, and Aikichi Iwamoto, and Zhongyang Wang, and Huanliang Liu
June 2019, Biochemical and biophysical research communications,
Copied contents to your clipboard!